Despite this methodological divergence, our PD‐L1 counts are aligned with the ones reported in the aforementioned pediatric IHC studies as those also showed low prevalence of PD‐L1 in similar solid pediatric tumor indications 9, 10, 12, 13, 14. The gene discussed is CD274; the disease is childhood neoplasm.